{"schema_version":"secwatch.filing_event.v1","accession":"0001636422-23-000086","form_type":"8-K","ticker":"HCAT","cik":"0001636422","company_name":"Health Catalyst, Inc.","filed_at":"2023-06-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:39.768320+00:00","generated_at":"2026-06-14T00:16:33.107046+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Health Catalyst stockholders elect directors, ratify auditor, approve exec compensation at annual meeting","bullets":["Elected Anita V. Pramoda and S. Dawn Smith as Class I directors for three-year terms expiring 2026.","Ratified Ernst & Young as independent auditor for FY2023 with 47,292,765 votes for, 108,336 against.","Advisory vote on named executive officer compensation approved with 40,672,307 for, 1,663,691 against.","Total shares outstanding: 56,259,662; 46,806,678 present at meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001636422-23-000086","json":"https://secwatch.observer/filing/0001636422-23-000086.json","markdown":"https://secwatch.observer/filing/0001636422-23-000086.md","text":"https://secwatch.observer/filing/0001636422-23-000086.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000086/0001636422-23-000086-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000086/hcat-20230614.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-14T00:16:33.107046+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3684e084986f2ce3ff083af3b5e9f7b863b0ca3a","claim":"Health Catalyst, Inc. shareholders approved Ratification of the appointment of Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending December 31, 2023 at the 2023-06-14 meeting.","evidence_excerpt":"Proposal 2 – Ratification of the Appointment of the Company’s Independent Registered Public Accounting Firm The Company’s stockholders ratified the appointment of Ernst & Young LLP to perform the audit of the Company’s consolidated financial statements for the fiscal year ending December 31, 2023. The results of such vote were as follows: Votes For Votes Against Abstentions 47,292,765 108,336 5,674","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000086/0001636422-23-000086-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"e4478e4e768f360ec30078bc2b05a28e31af53f6","claim":"Health Catalyst, Inc. shareholders approved Election of two Class I directors to serve three-year terms expiring at the 2026 annual meeting at the 2023-06-14 meeting.","evidence_excerpt":"Proposal 1 – Election of Directors The Company’s stockholders elected each of the two persons named below to serve as a Class I director of the Company to serve a three-year term expiring at the 2026 annual meeting of the stockholders or until their successors are duly elected and qualified, subject to their earlier removal or resignation. The results of such vote were as follows: Director Name Votes For Votes Withheld Broker Non-Votes Anita V. Pramoda 30,037,200 12,313,217 5,056,358 S. Dawn Smith 30,403,681 11,946,736 5,056,358","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000086/0001636422-23-000086-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"},{"claim_id":"f08f4c9829e33041894c8df1f844c90c9c787afb","claim":"Health Catalyst, Inc. shareholders approved Advisory, non-binding vote to approve the compensation of the Company’s named executive officers at the 2023-06-14 meeting.","evidence_excerpt":"Proposal 3 – Advisory, Non-Binding Vote to Approve the Compensation of the Company’s Named Executive Officers The stockholders approved the advisory, non-binding proposal to approve the compensation of the Company’s named executive officers. The results of such vote were as follows: Votes For Votes Against Abstentions Broker Non-Votes 40,672,307 1,663,691 14,419 5,056,358","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1636422/000163642223000086/0001636422-23-000086-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"say on pay"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-06-14"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}